Three-Tier Support Model for Adverse Childhood Experiences
Trial Summary
What is the purpose of this trial?
Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most communities is that health and education systems are fragmented and fail to accommodate families based upon different levels of need. This study utilizes cross-sectoral partnerships to mobilize three vectors (pediatricians, community health workers and parenting educators) to optimize the delivery of vital information and resources to a diverse population of families with ACEs. All vectors are trained in an evidence-informed curriculum to strengthen families and build youth resilience. The study design is a randomized controlled trial of 340 families of children between the ages of 3 to 11 who are generally healthy and have recently seen a pediatrician for a well-child visit. To evaluate the efficacy of this intervention, pediatric patients are invited to participate in repeat evaluations within 2 weeks, 3 months, 6 months, and 12 months after their well-child visit. The study will evaluate the following: 1) the association between Child-ACE scores and biomarkers of toxic stress at baseline in children age 3-11 years old; 2) whether the intervention reduces toxic stress and child health and psychosocial problems at follow-up for children with ACEs compared to usual well-child care for children with ACEs; and 3) the impact of mediating and moderating variables. These results will demonstrate that for families with ACEs the intervention will decrease toxic stress associated with ACEs, improve health outcomes, and reduce health disparities.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the Three-Tier Model treatment for adverse childhood experiences?
How does the Three-Tier Model treatment for adverse childhood experiences differ from other treatments?
The Three-Tier Model is unique because it offers a structured approach to addressing adverse childhood experiences (ACEs) by focusing on different levels of support, which may include individual, family, and community interventions. This model is distinct from other treatments as it aims to provide comprehensive support tailored to the specific needs of individuals affected by ACEs, rather than a one-size-fits-all solution.16789
Research Team
Ariane Marie-Mitchell, MD, PhD, MPH
Principal Investigator
Loma Linda University
Eligibility Criteria
This trial is for children aged 3-11 who have experienced adverse childhood events (ACEs) and are generally healthy. They must have recently had a well-child visit at a participating clinic. Children with significant congenital medical issues, those outside the age range, siblings already in the study, or those enrolled in a parenting program within the last year cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of Child-ACE scores and biomarkers of toxic stress
Intervention
Multi-component intervention involving pediatricians, community health workers, and parenting educators
Follow-up
Participants are monitored for changes in toxic stress and health outcomes
Treatment Details
Interventions
- Three-Tier Model
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor